biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The bioasis puppet

<< Previous

Bullboard Posts

Next >>

Post by TheTruth1234on Aug 21, 2023 7:30pm

119 Views

Post# 35598930

The bioasis puppet

Is so bent on DR for firing his useless pathetic butt, all he does is try to discredit her.

He blames her for HIS poor financial decisions.

Hey Johnny boy, its DRs fault you are in your 70s and bankrupt, right?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale